Disclosure Plus

EMnI Co., Ltd.: "Considering Stock Transfers, Capital Increases, and Convertible Bond Issuance… Nothing Has Been Finalized"

Shin Ha-yeon
2026-07-24 14:37:16
[Edaily Reporter Shin Ha-yeon ] On the 24th, EMnI Co., Ltd.(083470)announced in response to a request from the Korea Exchange (KRX) for a disclosure regarding significant market fluctuations that it is currently in discussions with third parties regarding a share transfer agreement involving a change in the largest shareholder, a capital increase through a rights offering, and the issuance of convertible bonds (CBs); however, no agreements have been finalized or signed to date.

The company stated separately that there are no other material matters to disclose regarding recent market fluctuations. It also explained that it plans to hold an extraordinary general meeting of shareholders on September 7 and will disclose the results following the meeting.

EMnI Co., Ltd. plans to issue a follow-up disclosure once specific details are finalized or within one month. The deadline for the follow-up disclosure is August 21.



Economy

Corporation

IT·Science

Economy

[Market Insight] “Will the Investment Boom in Rail and Telecommunications Networks Return?”… U.S. Pension Funds Warn Against Overinvestment in AI

During the era of massive railroad and telecommunications network construction in the United States, companies poured enormous amounts of capital into expanding railroad and fiber-optic networks in an…
2026-09-22 19:04:05

Corporation

"Even the 13-year-old grandson has stepped in"... The owner family's efforts to save a "penny stock" facing delisting

The families of owners at some mid-sized and small companies—facing the threat of delisting due to so-called “penny stocks” with share prices below 1,000 won—are actively buying back shares. Analysts …
2026-09-22 17:16:01

IT·Science

DuChemBio Co, LTD Holds 96.3% Share of Dementia Diagnostic Test Production Value… Highest in Three Years

It has been revealed that DuChemBio Co.,LTD.(176750)accounted for 96.3% of the domestic production value of radiopharmaceuticals used to diagnose Alzheimer’s disease last year. As domestic prescriptio…
2026-09-22 18:22:02